*Optimal dilutions/concentrations should be determined by the researcher.
Not tested in other applications.
293T , HeLaS3 , PC-12 , C8D30 , NIH-3T3 , Raw264.7 , C2C12
1XPBS, 20% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
1mg/ml(Please refer to the vial label for the specific concentration.)
Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of human DOCK1. The exact sequence is proprietary.
Purified by antigen-affinity chromatography.
For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
DOCK180 antibody, ced5 antibody, DOCK1 antibody, DOwnstream of CrK antibody, 180 kDa protein downstream of CRK antibody, dedicator of cytokinesis protein 1 antibody, dedicator of cyto-kinesis 1 antibody, dedicator of cytokinesis 1 antibody
This gene product binds to the SH3 domain of CRK protein. It may regulate cell surface extension and may have a role in the cell surface extension of an engulfing cell around a dying cell during apoptosis. [provided by RefSeq]